Glutathione Utilization by Candida albicans Requires a Functional Glutathione Degradation (DUG) Pathway and OPT7, an Unusual Member of the Oligopeptide Transporter Family
Open Access
- 1 December 2011
- journal article
- Published by Elsevier BV
- Vol. 286 (48), 41183-41194
- https://doi.org/10.1074/jbc.m111.272377
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Glutathione biosynthesis in the yeast pathogens Candida glabrata and Candida albicans: essential in C. glabrata, and essential for virulence in C. albicansMicrobiology, 2011
- Thioredoxin Regulates Multiple Hydrogen Peroxide-Induced Signaling Pathways in Candida albicansMolecular and Cellular Biology, 2010
- Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk DiffusionJournal of Clinical Microbiology, 2010
- Gln-222 in Transmembrane Domain 4 and Gln-526 in Transmembrane Domain 9 Are Critical for Substrate Recognition in the Yeast High Affinity Glutathione Transporter, Hgt1pPublished by Elsevier BV ,2009
- Dug1p Is a Cys-Gly Peptidase of the γ-Glutamyl Cycle of Saccharomyces cerevisiae and Represents a Novel Family of Cys-Gly PeptidasesJournal of Biological Chemistry, 2009
- Candida albicans Uses Multiple Mechanisms To Acquire the Essential Metabolite Inositol during InfectionInfection and Immunity, 2008
- MEGA: A biologist-centric software for evolutionary analysis of DNA and protein sequencesBriefings in Bioinformatics, 2008
- The Alternative Pathway of Glutathione Degradation Is Mediated by a Novel Protein Complex Involving Three New Genes in Saccharomyces cerevisiaeGenetics, 2007
- Epidemiology of Invasive Candidiasis: a Persistent Public Health ProblemClinical Microbiology Reviews, 2007
- Effects of Depleting the Essential Central Metabolic Enzyme Fructose-1,6-Bisphosphate Aldolase on the Growth and Viability of Candida albicans : Implications for Antifungal Drug Target DiscoveryEukaryotic Cell, 2006